Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Scientists Just Discovered That This Popular Vitamin Is Also Linked to Better Aging - AOL (opens in a new tab)

aol.com · 2026-09-15

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. 2 other points were not covered by the paper.

  • 3 supported
  • 1 overstated
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Three of six check out. Two claims the study doesn't address.

  • 3 supported
  • 1 overstated
  • 2 not covered
Open claim evidence
3
Source paper

Source layer

The 3 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedA new study published in Sleep Medicine suggests that older adults with certain health complications who took vitamin D did better on a cognitive test than those who were not on the supplement.View evidenceHide evidence

Why this verdict

The paper profile supports an association between vitamin D supplementation and higher MoCA only for the higher-dose category, ≥5000 IU daily, in a small cross-sectional sample with MCI/suspected MCI and disturbed sleep. Framing this broadly as participants who 'took vitamin D' doing better than non-users outruns the abstract-level evidence because lower doses were not associated with better scores.

1

Study evidence

Daily intake of ≥5000 IU vitamin D was associated with higher global cognitive performance (MoCA) compared with no daily vitamin D in adjusted regression models.Adjusted mean difference = 3.78 (SE 1.77); p = 0.039

“This cross-sectional study included 54 participants with diagnosed or suspected mild cognitive impairment (MCI) and disturbed sleep”
Claim 2 of 6Not coveredParticipants who took 5,000 IU or more of vitamin D a day scored more than 13 percent higher on the cognitive test than those who did not take the supplement, even after adjustment for BMI, age, and education; lower doses were not linked with better scores.View evidenceHide evidence

As statedmore than 13 percent higher; 5,000 IU or more daily

Why this verdict

The main direction and dose-specific association are supported: ≥5000 IU daily vitamin D was associated with a higher adjusted MoCA score versus no daily vitamin D, and lower doses were not significantly associated. The profile also supports covariate adjustment, though it lists age, sex, BMI, vitamin D type, and education, not only BMI, age, and education. However, the exact 'more than 13 percent higher' magnitude is not directly verifiable from the abstract profile, which reports an adjusted mean difference of 3.78 points rather than a percent difference.

1

Study evidence

Daily intake of ≥5000 IU vitamin D was associated with higher global cognitive performance (MoCA) compared with no daily vitamin D in adjusted regression models.Adjusted mean difference = 3.78 (SE 1.77); p = 0.039

“This cross-sectional study included 54 participants with diagnosed or suspected mild cognitive impairment (MCI) and disturbed sleep”
Claim 3 of 6Not coveredThe article says a 2023 study in Alzheimer’s & Dementia Diagnosis, Assessment, & Disease Monitoring found that nearly 12,500 older adults who took vitamin D had a 40 percent lower risk of developing dementia, and women had a 49 percent lower risk if they took vitamin D.View evidenceHide evidence

As stated40 percent lower risk; 49 percent lower risk in women; nearly 12,500 older adults

Why this verdict

This claim concerns a separate 2023 Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring study. The supplied paper profile is abstract-depth for the Sleep Medicine paper and does not provide evidence about that separate study’s sample size or dementia-risk estimates, so the claim cannot be verified from the supplied profile.

Claim 4 of 6SupportedIn the cross-sectional study, 54 older adults with mild cognitive impairment and disturbed sleep, or suspected to have those conditions, completed the Montreal Cognitive Assessment and were compared by vitamin D supplement use.View evidenceHide evidence

As stated54 participants

Why this verdict

The abstract profile states that this was a cross-sectional study of 54 participants with diagnosed or suspected MCI and disturbed sleep, that MoCA was administered, and that vitamin D supplement intake was assessed and analyzed in relation to MoCA scores.

1

Study evidence

Daily intake of ≥5000 IU vitamin D was associated with higher global cognitive performance (MoCA) compared with no daily vitamin D in adjusted regression models.Adjusted mean difference = 3.78 (SE 1.77); p = 0.039

“This cross-sectional study included 54 participants with diagnosed or suspected mild cognitive impairment (MCI) and disturbed sleep”
Claim 5 of 6SupportedThe researchers concluded that higher daily vitamin D supplementation is associated with better overall cognitive performance in this population.View evidenceHide evidence

Why this verdict

This matches the paper profile’s discussion-level conclusion: higher daily vitamin D supplementation, specifically the ≥5000 IU category, was associated with better global cognitive performance on MoCA in this MCI plus sleep-disturbance sample. The claim is appropriately associational.

1

Study evidence

Daily intake of ≥5000 IU vitamin D was associated with higher global cognitive performance (MoCA) compared with no daily vitamin D in adjusted regression models.Adjusted mean difference = 3.78 (SE 1.77); p = 0.039

“This cross-sectional study included 54 participants with diagnosed or suspected mild cognitive impairment (MCI) and disturbed sleep”
Claim 6 of 6SupportedThe article emphasizes that the latest study was small and observational, so it cannot show that taking more than 5,000 IU of vitamin D daily will boost brain aging or cognition.View evidenceHide evidence

As statedmore than 5,000 IU daily

Why this verdict

The paper profile explicitly identifies the study as small and cross-sectional/observational and lists inability to establish causality as a limitation. The story’s caution that the finding does not show that high-dose vitamin D will boost cognition or brain aging is consistent with those limitations, though the profile’s dose category is ≥5000 IU daily rather than strictly more than 5000 IU.

1

Study evidence

Daily intake of ≥5000 IU vitamin D was associated with higher global cognitive performance (MoCA) compared with no daily vitamin D in adjusted regression models.Adjusted mean difference = 3.78 (SE 1.77); p = 0.039

“This cross-sectional study included 54 participants with diagnosed or suspected mild cognitive impairment (MCI) and disturbed sleep”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Vitamin D supplement intake was self-reported, and the abstract profile does not report serum 25(OH)D or other biomarker confirmation.

    The story’s listed caveats do not mention self-reported exposure measurement or lack of biomarker confirmation, which are interpretation-relevant limitations.

    From Cross-sectional observational

  • Potential residual confounding remains despite adjustment for listed covariates.

    The story notes the study is observational, which partly gestures at confounding, but it does not specifically identify residual confounding as a limitation of interpreting the vitamin D association.

    From Cross-sectional observational; Cross-sectional multivariable linear regression

  • The abstract also reports no significant MoCA difference between vitamin D3 and D2 users.

    The story mentions dose findings but does not reflect the vitamin D type finding.

    From Cross-sectional observational

  • The same adjusted model reported that having a college degree and being overweight were each associated with higher MoCA scores.

    These supporting covariate associations are part of the paper profile but are not discussed in the story presentation.

    From Cross-sectional multivariable linear regression

5 things the story did carry across
  • The paper’s central result is a dose-specific cross-sectional association: daily vitamin D intake of ≥5000 IU was associated with higher MoCA score versus no daily vitamin D in adjusted regression.
  • The study population and design were 54 adults with diagnosed or suspected mild cognitive impairment and disturbed sleep, assessed with MoCA in a cross-sectional observational analysis.
  • Lower daily vitamin D doses were not significantly associated with higher MoCA scores.
  • The adjusted model controlled for age, sex, BMI, education, and vitamin D type.
  • The study was small and cross-sectional, so it cannot establish causality or temporal ordering between supplementation and cognition; findings are preliminary.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoAssess whether vitamin D supplement intake (dose/type) is associated with global cognitive performance among people with mild cognitive impairment (diagnosed or suspected) and sleep disturbance.Cross-sectional observationalExpand

In plain English

Cross-sectional analysis (n=54) of adults with diagnosed or suspected mild cognitive impairment (MCI) and sleep disturbance examining associations between self-reported vitamin D supplement intake (dose and type) and global cognition (MoCA) using adjusted linear regression.

Key findings

  • Daily intake of ≥5000 IU vitamin D was associated with higher global cognitive performance (MoCA) compared with no daily vitamin D in adjusted regression models.Adjusted mean difference = 3.78 (SE 1.77); p = 0.039
  • No significant difference in MoCA score was observed between participants who regularly took vitamin D3 versus D2.
“This cross-sectional study included 54 participants with diagnosed or suspected mild cognitive impairment (MCI) and disturbed sleep”
What this piece can’t prove
  • Cross-sectional design prevents causal inference and temporal ordering between supplementation and cognition.
  • Small sample size (n=54) limits precision and statistical power.
  • Vitamin D supplement intake was self-reported; abstract does not report serum 25(OH)D or other biomarker confirmation.
  • Sleep disturbance classification and cognitive assessment rely on questionnaire and test administration reported in abstract; potential measurement error.
  • Potential residual confounding despite adjustment for listed covariates; detailed covariate handling not provided in abstract.
2human in vivoCharacterize covariate associations (e.g., education, BMI/overweight status, age/sex) with MoCA scores within this MCI + sleep disturbance sample while adjusting for vitamin D supplementation variables.Cross-sectional multivariable linear regressionExpand

In plain English

In a cross-sectional sample of 54 individuals with mild cognitive impairment and sleep disturbance, adjusted multivariable linear regression reported that having a college degree and being overweight were each associated with higher total MoCA scores (adjusted mean differences 3.14 and 3.59 points, respectively); age and sex were included as covariates but adjusted estimates for them were not reported in the abstract.

Key findings

  • Having a college degree was significantly associated with a higher total MoCA score in the adjusted multivariable model.Adjusted mean difference = 3.14 (SE = 1.38); p = 0.031
  • Overweight status was significantly associated with a higher total MoCA score in the adjusted model.Adjusted mean difference = 3.59 (SE = 1.36); p = 0.013
“Having a college degree was significantly associated with a higher total MoCA score”
What this piece can’t prove
  • Cross-sectional design — associations cannot establish causality.
  • Small sample size (n = 54) — limited precision and generalizability.
  • Vitamin D supplement intake was self-reported; potential measurement error.
  • Sleep disturbance defined by questionnaire (PSQI/ESS); no objective sleep measures reported.
  • Abstract does not report adjusted estimates for some covariates (age, sex), limiting full evaluation of covariate effects.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 18 candidate papers

Candidate

The validity of the Montreal cognitive assessment (Cantonese version) as a screening tool for mild cognitive impairment in Hong Kong Chinese

Crossref

Source (opens in a new tab)

And 12 more candidates considered.